EXSCIEN CORPORATION

Company Information
Address 1044 EAST CHESTNUT ST
LOUISVILLE, KY, 40204-6033

http://www.exsciencorp.com

Information

DUNS: 968503164

# of Employees: 5


Ownership Information

HUBZone Owned: Y

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Novel Mitochondrial DNA Repair Enzyme for Heart Failure

    Amount: $296,503.00

    ABSTRACT Previous studies have demonstrated that heart failure triggers and sustains increases in oxidative stress inducing mitochondrial DNA mtDNA damage that then propagates myocardial injury res ...

    SBIRPhase I2017Department of Health and Human Services National Institutes of Health
  2. Mitochondrial TAT-DNA repair proteins for treatment of insulin resistance

    Amount: $296,128.00

    DESCRIPTION provided by applicant Insulin resistance IR also known as metabolic syndrome is tied to obesity and is associated with numerous modern health problems including the growing problems ...

    STTRPhase I2016Department of Health and Human Services
  3. Mitochondrial DNA repair agents for acute lung injury

    Amount: $3,196,272.00

    DESCRIPTION provided by applicant Attempts to develop drug treatments for acute lung injury ALI and the acute respiratory distress syndrome ARDS have been marred by unfulfilled expectations S ...

    SBIRPhase II2015Department of Health and Human Services National Institutes of Health
  4. Minimal piggyBac vectors for chromatin integration

    Amount: $150,576.00

    In this grant, we describe novel transposon piggyBac vectors engineered to deliver transgenes as efficiently as currently available piggyBac systems, but with significantly less helper DNA co-delivere ...

    STTRPhase I2014Department of Health and Human Services
  5. Enhancing mtDNA Repair During Stroke Reperfusion to Reduce Brain Damage

    Amount: $224,989.00

    DESCRIPTION (provided by applicant): Attempts to develop drug treatments for acute stroke have not fulfilled expectations. Perhaps best illustrating this unsatisfactory situation is the hisory of ther ...

    STTRPhase I2014Department of Health and Human Services
  6. Mitochondrial DNA repair agents for acute lung injury

    Amount: $154,758.00

    DESCRIPTION (provided by applicant): Drug development for acute lung injury (ALI) has been marred by unfulfilled expectations. Perhaps best illustrating this unsatisfactory situation is the history o ...

    STTRPhase I2012Department of Health and Human Services

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government